A clinical study to Evaluate antipyretic effect of Febrikid plus tablet in Childre
Phase 2
- Conditions
- Health Condition 1: B999- Unspecified infectious disease
- Registration Number
- CTRI/2023/07/055248
- Lead Sponsor
- Parul Ayurveda Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Temperature between 99- 103 oF.
2.Fever of acute onset without any complications i.e. dehydration, convulsion, etc.
3.Acute onset fever of 1 to 3 days.
4.Patient of either sex suffering from fever of age 3-12 years.
5.Children with parents who agree to participate and sign the informed consent
Exclusion Criteria
1.Fever more than 3 days.
2.Chronic fever ( > 5 days) associated with poor hemodynamic and clinical outcomes.
3.Any febrile condition of children requiring an immediate intervention depending of history and general condition at the point of examination as found by the investigators non inducible was be excluded from study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced in Fever & Body Temerature <br/ ><br>Reduced in Body ache & headache <br/ ><br>Improvement in appetiteTimepoint: At baseline <br/ ><br>On Day 2 <br/ ><br>Day 3 <br/ ><br>Day 5
- Secondary Outcome Measures
Name Time Method Improvement in Leg cramps <br/ ><br>Improvement in Weakness <br/ ><br>Reduced IrritabilityTimepoint: 4 days <br/ ><br>5 days <br/ ><br>6 days